Oscar Health Inc. (OSCR) Misses Q4 EPS by 35c; offers guidance

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($1.24), $0.35 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $3.11 billion.

GUIDANCE:

Oscar Health Inc. sees FY2026 revenue of $18.7-19 billion, versus the consensus of $12.756 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results